TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
AGIO

Agios Pharmaceuticals, Inc.

Healthcare · Biotechnology

32.60$ -1.0% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Agios Pharmaceuticals, Inc. (AGIO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 1,108 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet AGIO
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
1,007 937 850 773 1,792 1,663 1,556 1,471 1,386 1,297 1,185 1,108
704 834 664 632 1,074 966 969 1,019 1,033 942 835 718
64 88 119 85 254 76 79 81 93 89 114 100
647 777 598 570 1,005 894 893 939 953 854 737 618
1.2 2.8 3.5 3.8 3.1 4.1 3.3 5.0 5.0 11 16 20
17 19 23 24 26 28 30 31 32 33 35 30
74 – – – – – – – – – – –
120 126 106 113 165 122 89 102 101 104 76 82
58 68 52 63 119 81 52 70 75 82 59 70
15 15 15 16 16 17 17 18 18 18 19 19
13 9.8 11 10 17 17 14 18 20 18 14 16
887 811 744 661 1,627 1,541 1,467 1,370 1,284 1,193 1,109 1,026
-727 -823 -904 -1,000 -52 -149 -238 -350 -454 -562 -661 -762
56 56 56 57 58 57 57 58 58 58 59 59

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?